Titan Medical Inc (NASDAQ:TMDI) is seeing selling pressure in pre-market trading after the news.
As of 9.14, TMDI stock is trading lower by 5.29% at $1.61.
TMDI Issues News
Titan Medical Reports First Quarter 2021 Financial Results and Provides Board Update
- Titan had cash and cash equivalents of $53.4 million, compared to $25.5 million at December 31, 2020.
- Since December 31, 2020, the company has received $10 million from the exercise of warrants and aggregate gross proceeds of $34.5 million from two financings that closed during the first quarter 2021.
- Net and comprehensive loss for the three months ended March 31, 2021 was $14.8 million, compared with a net and comprehensive loss of $0.8 million, for the three months ended March 31, 2020.
- In the first quarter of 2020, R&D expenses were $0.05 million as the company had temporarily suspended its R&D activities.
|SHARES OUTSTANDING||109.53 M|
|SHARE FLOAT (%)||109.38 M (99.86%)|
|% HELD BY INSTITUTIONS||3.96|
Recent Stock Performance
|+/- EMA(20)||1.67 (+1.80%)|
|+/- SMA(50)||1.75 (-2.86%)|
|+/- SMA(200)||1.43 (+18.88%)|
|CCI20||31.2687||Neutral||Chaikin Money Flow||0.1964||Buy|
|MACD||-0.0786||Sell||Money Flow Index||38.7660||Sell|
|STOCH (14,3)||57.1429||Neutral||STOCH RSI||0.8345||OverBought|